Biclonal expansion and heterogeneous lineage involvement in a case of chronic myeloproliferative disease with concurrent MPLW515L/JAK2V617F mutation

被引：14

作者：

Hussein, Kais ^{[1
]}

Bock, Oliver ^{[1
]}

Theophile, Katharina ^{[1
]}

Schlue, Jerome ^{[1
]}

Ballmaier, Matthias ^{[1
]}

Kroeger, Nicolaus ^{[1
]}

Goehring, Gudrun ^{[1
]}

Buesche, Guntram ^{[1
]}

Kreipe, Hans ^{[1
]}

机构：

[1] Hannover Med Sch, Inst Pathol, D-30625 Hannover, Germany

来源：

BLOOD | 2009年 / 113卷 / 06期

关键词：

JAK2(V617F) MUTATION; POLYCYTHEMIA-VERA; MYELOFIBROSIS; DISORDERS; JAK2V617F; CELLS; JAK2;

D O I：

10.1182/blood-2008-01-136499

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1391 / 1392

页数：2

共 10 条

[1] Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis [J].

Chaligne, Ronan ;

James, Chloe ;

Tonetti, Carole ;

Besancenot, Rodolphe ;

Pierre Le Couedic, Jean ;

Fava, Fanny ;

Mazurier, Frederic ;

Godin, Isabelle ;

Maloum, Karim ;

Larbret, Frederic ;

Lecluse, Yann ;

Vainchenker, William ;

Giraudier, Stephane .

BLOOD, 2007, 110 (10) :3735-3743

[2] Familial polycythemia vera with non-germ line JAK2V617F mutation sparing the abnormal and clonal granulopoiesis [J].

Hussein, K. ;

Bock, O. ;

Ballmaier, M. ;

Goehring, G. ;

Steinemann, D. ;

Lehmann, U. ;

Kemper, J. ;

Buhr, T. ;

Kreipe, H. .

LEUKEMIA, 2007, 21 (12) :2566-2568

[3] Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation [J].

Hussein, Kais ;

Bock, Oliver ;

Seegers, Anna ;

Flasshove, Michael ;

Henneke, Felicitas ;

Buesche, Guntram ;

Kreipe, Hans Heinrich .

BLOOD, 2007, 109 (09) :4106-4107

[4] Different involvement of the megakaryocytic lineage by the JAK2V617F mutation in Polycythemia vera, essential thrombocythemia and chronic idiopathic myelofibrosis [J].

Hussein, Kais ;

Brakensiek, Kai ;

Buesche, Guntram ;

Buhr, Thomas ;

Wiese, Birgitt ;

Kreipe, Hans ;

Bock, Oliver .

ANNALS OF HEMATOLOGY, 2007, 86 (04) :245-253

[5] Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders [J].

Kralovics, Robert ;

Teo, Soon-Siong ;

Li, Sai ;

Theocharides, Alexandre ;

Buser, Andreas S. ;

Tichelli, Andre ;

Skoda, Radek G. .

BLOOD, 2006, 108 (04) :1377-1380

[6] Concurrent MPL515 and JAK2V617F mutations in myelofibrosis:: chronology of clonal emergence and changes in mutant allele burden over time [J].

Lasho, Terra L. ;

Pardanani, Animesh ;

McClure, Rebecca F. ;

Mesa, Ruben A. ;

Levine, Ross L. ;

Gilliland, D. Gary ;

Tefferi, Ayalew .

BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (05) :683-687

[7] Extending Jak2V617F and MplW515 mutation analysis to single hematopoietic colonies and B and T lymphocytes [J].

Pardanani, Animesh ;

Lasho, Terra L. ;

Finke, Christy ;

Mesa, Ruben A. ;

Hogan, William J. ;

Ketterling, Rhett P. ;

Gilliland, Dwight Gary ;

Tefferi, Ayalew .

STEM CELLS, 2007, 25 (09) :2358-2362

[8] Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms [J].

Tefferi, A. ;

Vardiman, J. W. .

LEUKEMIA, 2008, 22 (01) :14-22

[9] Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice [J].

Tiedt, Ralph ;

Hao-Shen, Hui ;

Sobas, Marta A. ;

Looser, Renate ;

Dirnhofer, Stephan ;

Schwaller, Juerg ;

Skoda, Radek C. .

BLOOD, 2008, 111 (08) :3931-3940

[10] JAK2V617F mutation can occur exclusively in the erythroid lineage and be absent in granulocytes and progenitor cells in classic myeloproliferative disorders [J].

Zehentner, Barbara K. ;

Loken, Michael R. ;

Wells, Denise A. .

AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (10) :806-807

← 1 →